Nicergoline in Dementia
Explore this paper's citation graph
Summary
Overall, data strongly support the hypothesis that nicergoline might interfere with fundamental molecular mechanisms underlying cognitive processes in vivo in patients with dementing illnesses.
- Type
- article
- Published
- 2000-10-01
- Cited by
- 28
- References
- 79
- OpenAlex
- https://openalex.org/W80035426
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:68104177
Keywords
Dementia, Cognitive decline, Cholinergic, Neuroscience, Cognitive disorder
References
- Inflammatory mechanisms in Alzheimer's disease: implications for therapy.
- Plasma binding of an alpha-blocking agent, nicergoline--affinity for serum albumin and native and modified alpha 1-acid glycoprotein.
- Studies on the metabolism of ergoline derivatives. Metabolism of nicergoline in man and in animals.
- Psychological measurements in psychopharmacology
- Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study.
- Nicergoline in Mild to Moderate Dementia
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician
- A new rating scale for Alzheimer's disease.
- Pharmacological basis for the clinical effects of nicergoline in dementia
- Attenuated protein kinase C activity and translocation in Alzheimer's disease brain.
- Criteria for vascular dementia: replacing dogma with data.
- Free and total lipid myo-inositol concentrations decrease with age in human brain.
- Possible involvement of nitric oxide in long-term potentiation.
- Effects of nicergoline on age-related decrements in radial maze performance and acetylcholine levels.
- Overlap between pathology of Alzheimer disease and vascular dementia.
- Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease.
- Long-Term Nicergoline Treatment of Mild to Moderate Senile Dementia
- Induction of apoptosis by the low-affinity NGF receptor.
- Effect of recombinant human nerve growth factor on presynaptic cholinergic function in rat hippocampal slices following partial septohippocampal lesions: measures of [3H]acetylcholine synthesis, [3H]acetylcholine release and choline acetyltransferase activity.
- Brain protection of nicergoline against hypoxia: EEG brain mapping and psychometry
Cited by
- Nicergoline in the Treatment of Mild- to- Moderate Alzheimer's Disease
- Ergotamine and nicergoline — Facts and myths
- Neuroprotection and aging of the cholinergic system: a role for the ergoline derivative nicergoline (Sermion).
- Therapeutic Use of Nicergoline
- Nicergoline in Balance Alterations in Adult and Elderly Patients
- Plasticity of GABA(a) system during ageing: focus on vestibular compensation and possible pharmacological intervention.
- Clinical pharmacology of anti‐Alzheimer drugs
- Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against beta-amyloid toxicity.
- [On the question of the organization of brain function: cortical associations, «disconnection» syndrome and higher brain functions].
- Деменция вследствие поражения мелких церебральных сосудов: современные представления о патогенезе и терапии
- Changes in Regional Cerebral Perfusion after Nicergoline Treatment in Early Alzheimer's Disease: A Pilot Study
- Effects of nicergoline treatment on regional cerebral blood flow in early Alzheimer's disease
- Efficacy of nicergoline treatment in Parkinson's disease associated with dementia.
- Применение ницерголина (Сермиона) в комплексной терапии деменций позднего возраста в амбулаторой практике
- Urtica dioica extracts abolish scopolamine-induced neuropathies in rats
- [Efficacy of Sermion in the treatment of tinnitus noise in patients with chronic cerebrovascular pathology].
- Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs
- Biological studies of clavine alkaloids targeting CNS receptors
- Сочетание нейродегенеративных и сосудистых механизмов в патогенезе деменций позднего возраста
- Применение ницерголина в геронтологической практике
Related papers
- New cardiovascular targets to prevent late onset Alzheimer disease.
- Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population.
- Antidiabetic therapies and Alzheimer disease
- Dietary Approaches and Supplements in the Prevention of Cognitive Decline and Alzheimer's Disease.
- [Biological markers in the diagnosis of dementia and Alzheimer's disease].
- MY APPROACH to a patient with atrial fibrillation and dementia.
- Homocysteine, B Vitamins, and Cognitive Impairment.
- Cognitive changes in young-old adults: effect of family history of dementia.